Primary Handling Editors: Liam Messin and Sonia Muliyil, in collaboration with the Nature Medicine team
Lower baseline insulin doses, shorter duration of diabetes, and lower HbA1c levels were associated with greater success in transitioning from insulin to a GLP-1 agonist [34, 35]
As demand for new weight loss medications grows, there is increased focus on the insurance coverage landscape
For branded medications, prescriptions go through licensed retail or specialty pharmacies
Ozempic offers doses from 0.25 mg to 2.0 mg, while Mounjaro pens are single-use and range from 2.5 mg to 15 mg, depending on your prescription
Individual response varies some patients lose 20% on semaglutide